The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy

Geahča maid

• The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.
  Dahkki: Prevo, R, et al.
  Almmustuhtton: (2012)
• ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
  Dahkki: Fokas, E, et al.
  Almmustuhtton: (2013)
• Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.
  Dahkki: Fokas, E, et al.
  Almmustuhtton: (2012)
• Targeting ATR in DNA damage response and cancer therapeutics.
  Dahkki: Fokas, E, et al.
  Almmustuhtton: (2014)
• Targeting ATR in DNA damage response and cancer therapeutics
  Dahkki: Fokas, E, et al.
  Almmustuhtton: (2014)